Incidence and Outcomes of Significant Weight Changes After Pancreas Transplant Alone.
Journal
Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
22
11
2019
revised:
29
12
2019
accepted:
03
01
2020
entrez:
21
3
2020
pubmed:
21
3
2020
medline:
21
3
2020
Statut:
epublish
Résumé
Weight change, primarily weight gain, is a common problem among solid organ transplant recipients. The incidence of weight gain or loss after successful pancreas transplant alone (PTA) and the effect on graft survival is unknown. This was a single-center observational study among PTA recipients, transplanted at our center between January 1, 2005, and July 31, 2017, who had a functional pancreas graft for at least 1 year and documented weight change at the 1-year clinic visit. In this cohort study of 105 PTA recipients, 28 had significant weight gain, 27 had significant weight loss, and the remaining 50 did not have significant weight change at 1-year posttransplant. When comparing the weight gain and no weight change groups, the weight gain cohort started to gain weight at 3 months posttransplant to 5 years or last follow up. Similarly, the weight loss group lost weight at 3 months posttransplant up to last follow up. Clinically significant weight gain or weight loss were not associated with uncensored or death censored graft failure in univariate regression and Kaplan-Meier survival analysis. Also, there were no significant differences between the groups in the glycated hemoglobin at last follow up. Approximately 50% of PTA recipients had a significant weight change at 1-year posttransplant, of which 25% gained significant weight and 25% loss. There was no significant difference in graft survival due to the significant weight changes. Further research is needed in this field.
Sections du résumé
BACKGROUND
BACKGROUND
Weight change, primarily weight gain, is a common problem among solid organ transplant recipients. The incidence of weight gain or loss after successful pancreas transplant alone (PTA) and the effect on graft survival is unknown.
METHODS
METHODS
This was a single-center observational study among PTA recipients, transplanted at our center between January 1, 2005, and July 31, 2017, who had a functional pancreas graft for at least 1 year and documented weight change at the 1-year clinic visit.
RESULTS
RESULTS
In this cohort study of 105 PTA recipients, 28 had significant weight gain, 27 had significant weight loss, and the remaining 50 did not have significant weight change at 1-year posttransplant. When comparing the weight gain and no weight change groups, the weight gain cohort started to gain weight at 3 months posttransplant to 5 years or last follow up. Similarly, the weight loss group lost weight at 3 months posttransplant up to last follow up. Clinically significant weight gain or weight loss were not associated with uncensored or death censored graft failure in univariate regression and Kaplan-Meier survival analysis. Also, there were no significant differences between the groups in the glycated hemoglobin at last follow up.
CONCLUSIONS
CONCLUSIONS
Approximately 50% of PTA recipients had a significant weight change at 1-year posttransplant, of which 25% gained significant weight and 25% loss. There was no significant difference in graft survival due to the significant weight changes. Further research is needed in this field.
Identifiants
pubmed: 32195330
doi: 10.1097/TXD.0000000000000983
pmc: PMC7056274
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e539Informations de copyright
Copyright © 2020 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest.
Références
Obesity (Silver Spring). 2015 Dec;23(12):2319-20
pubmed: 26523739
CMAJ. 2011 Mar 8;183(4):443-9
pubmed: 21324857
Eur J Gastroenterol Hepatol. 2016 Jan;28(1):107-15
pubmed: 26469355
J Occup Environ Med. 2013 Mar;55(3):318-24
pubmed: 23247606
J Heart Lung Transplant. 2009 Nov;28(11):1150-7
pubmed: 19782581
Transplant Proc. 2014 Jul-Aug;46(6):1735-40
pubmed: 25131024
Aust N Z J Psychiatry. 2009 Sep;43(9):812-7
pubmed: 19670054
Transpl Int. 2016 Jul;29(7):810-8
pubmed: 26859581
Curr Obes Rep. 2017 Jun;6(2):187-194
pubmed: 28455679
J Clin Psychiatry. 1999;60 Suppl 21:16-9
pubmed: 10548137
Am J Transplant. 2008 Mar;8(3):667-72
pubmed: 18294163
Transplantation. 2019 Sep;103(9):1928-1934
pubmed: 31233481
Clin Transplant. 2008 May-Jun;22(3):354-9
pubmed: 18279417
Insights Imaging. 2010 Nov;1(5-6):339-347
pubmed: 22347927
Transpl Int. 2005 Apr;18(4):461-6
pubmed: 15773968
Endocr Rev. 2004 Dec;25(6):919-46
pubmed: 15583023
J Heart Lung Transplant. 2006 Jan;25(1):36-41
pubmed: 16399528
Transplantation. 2020 Mar;104(3):632-639
pubmed: 31335775
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
Transplantation. 2019 Feb;103(2):435-440
pubmed: 29994978
J Heart Lung Transplant. 2003 Aug;22(8):894-902
pubmed: 12909470
Prog Transplant. 2007 Mar;17(1):40-7
pubmed: 17484244
Ann Transplant. 2009 Jul-Sep;14(3):45-50
pubmed: 19644159
Am J Transplant. 2013 Jan;13 Suppl 1:73-102
pubmed: 23237697
Curr Opin Organ Transplant. 2010 Feb;15(1):112-8
pubmed: 20009931
Am J Kidney Dis. 2003 Feb;41(2):480-7
pubmed: 12552513
Health Aff (Millwood). 2011 Sep;30(9):1673-9
pubmed: 21900657
Adv Exp Med Biol. 2017;960:1-17
pubmed: 28585193
Syst Rev. 2015 Jan 06;4:2
pubmed: 25563983
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Transpl Int. 2018 Jan;31(1):32-37
pubmed: 28672081
Diabetes Care. 2004 Jan;27 Suppl 1:S105
pubmed: 14693941
J Heart Lung Transplant. 2005 Nov;24(11):1757-62
pubmed: 16297777
J Heart Lung Transplant. 2010 Sep;29(9):1026-33
pubmed: 20558085
Am J Kidney Dis. 2001 Aug;38(2):349-53
pubmed: 11479161